胃轻瘫患者的流行病学与医疗资源利用:一项系统综述
该系统综述检索5个数据库至2022年1月,纳入13项研究(数据1994至2019年),除1项来自英国外均基于美国。明确胃轻瘫患病率为每10万成人13.8至267.7例,发病率为每10万人年1.9至6.3例;1型糖尿病和2型糖尿病的10年累积发病率分别为5.2%和1.0%。胃轻瘫住院和急诊就诊率在约20年间增加2至18倍,死亡率高于一般人群。
要点
- 明确胃轻瘫患病率为每10万成人13.8至267.7例,发病率为每10万人年1.9至6.3例。
- 1型糖尿病和2型糖尿病的10年累积发病率分别为5.2%和1.0%。
- 胃轻瘫住院和急诊就诊率在约20年间增加2至18倍,死亡率高于一般人群。
核心结论
- 缺乏高质量、人群多样化且基于人群的研究来准确描述胃轻瘫的流行病学。
- 未来需要采用有效胃排空测量的研究来更好地描述胃轻瘫的流行病学和自然史。
研究设计与样本
- 系统综述,检索5个数据库截至2022年1月发表的所有语言、年份和国家关于胃轻瘫流行病学的研究,采用预设检索策略。
- 共纳入13项研究,数据来自1994年至2019年;除1项来自英国外,其余均基于美国。
主要发现
- 明确胃轻瘫(症状加胃排空延迟)患病率为每10万成人13.8至267.7例,发病率为每10万人年1.9至6.3例。
- 1型糖尿病和2型糖尿病的10年累积发病率分别为5.2%和1.0%。
- 各研究中胃轻瘫在女性和糖尿病患者中更常见。
- 胃轻瘫住院和急诊就诊率在约20年间增加2至18倍。
- 可能或明确胃轻瘫患者的死亡率高于一般人群,主要死因为心血管疾病、呼吸衰竭和恶性肿瘤;多项研究观察到20世纪90年代中期至2000年代末住院死亡率改善。
局限性
- 多数研究(76.9%)仅使用国际疾病分类编码或临床记录诊断进行病例识别;2项研究(15.4%)使用客观评估诊断胃轻瘫。
- 仅4项研究(30.8%)使用非专科社区数据库;其余9项研究使用住院、急诊或疾病特异性数据库。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The authors performed a systematic review of epidemiologic data to understand the prevalence, incidence, etiologies, and hospitalizations related to gastroparesis (GP). METHODS: Studies of the epidemiology of GP published in all languages, years, and countries from 5 databases in January 2022 were studied using prespecified search strategies. RESULTS: Thirteen studies (data from 1994 to 2019) were included. All but one study (from the United Kingdom) were based in the United States. Prevalence of definite GP (symptoms plus delayed gastric emptying) ranged from 13.8 to 267.7 per 100,000 adults, and incidence was 1.9-6.3 per 100,000 person-years. The estimated 10-year cumulative incidence of GP in type 1 diabetes (DM) and type 2 DM was 5.2% and 1.0%, respectively. Across studies, GP was more common among female patients and those with DM. Rates of hospitalizations and emergency department visits for GP are increasing, ranging from 2- to 18-fold over approximately 2 decades. Mortality rates for patients with possible or definite GP were higher compared with the general population, with primary causes of death in GP being cardiovascular, respiratory failure, and malignancy. Multiple studies observed improved inpatient mortality over the mid-1990s to late 2000s. Limitations include the case identification in most studies (76.9%) used solely International Classification of Diseases codes or clinical record diagnoses; 2 studies (15.4%) used objective evaluation to diagnose GP. Only 4 studies (30.8%) used non-specialized community databases; the remaining 9 studies used inpatient, emergency department, or disease-specific databases. CONCLUSIONS: There is a paucity of high-quality, demographically diverse, and population-based studies to accurately describe the epidemiology of GP. Future studies with valid gastric emptying measurement are needed to better characterize the epidemiology and natural history of GP.
引用
- Dilmaghani S, Zheng T, Camilleri M, et al. Epidemiology and Healthcare Utilization in Patients With Gastroparesis: A Systematic Review. Clin Gastroenterol Hepatol. 2022. PMID: 35870768. doi:10.1016/j.cgh.2022.07.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。